David Hallengärd

1.1k total citations
27 papers, 772 citations indexed

About

David Hallengärd is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, David Hallengärd has authored 27 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Virology, 12 papers in Immunology and 9 papers in Infectious Diseases. Recurrent topics in David Hallengärd's work include HIV Research and Treatment (12 papers), Immunotherapy and Immune Responses (8 papers) and Transgenic Plants and Applications (6 papers). David Hallengärd is often cited by papers focused on HIV Research and Treatment (12 papers), Immunotherapy and Immune Responses (8 papers) and Transgenic Plants and Applications (6 papers). David Hallengärd collaborates with scholars based in Sweden, United Kingdom and Estonia. David Hallengärd's co-authors include Peter Liljeström, Beate M. Kümmerer, Mariano Estéban, Andreas Bråve, Andres Merits, Juan García‐Arriaza, Pierre Roques, Britta Wahrén, Roger Le Grand and Aleksei Lulla and has published in prestigious journals such as PLoS ONE, Oncogene and Journal of Virology.

In The Last Decade

David Hallengärd

26 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Hallengärd Sweden 16 434 373 200 187 172 27 772
Alan King United States 14 467 1.1× 484 1.3× 279 1.4× 235 1.3× 130 0.8× 18 1.1k
Jorge Reyes‐del Valle United States 12 399 0.9× 374 1.0× 105 0.5× 156 0.8× 73 0.4× 15 721
Wataru Akahata United States 16 958 2.2× 931 2.5× 179 0.9× 267 1.4× 218 1.3× 26 1.4k
Jérôme Salmon United States 17 270 0.6× 347 0.9× 200 1.0× 280 1.5× 84 0.5× 19 836
Michael G. Raum United States 7 292 0.7× 293 0.8× 215 1.1× 241 1.3× 332 1.9× 9 803
Lesley C. Dupuy United States 17 471 1.1× 216 0.6× 104 0.5× 244 1.3× 72 0.4× 29 819
Jayati Mullick India 15 246 0.6× 104 0.3× 306 1.5× 107 0.6× 102 0.6× 35 791
Itaru Anraku Australia 11 643 1.5× 660 1.8× 133 0.7× 110 0.6× 115 0.7× 12 894
S. Kyle Austin United States 16 1.1k 2.6× 1.3k 3.5× 99 0.5× 127 0.7× 128 0.7× 18 1.5k
Samantha Brandler France 13 579 1.3× 505 1.4× 129 0.6× 100 0.5× 151 0.9× 13 911

Countries citing papers authored by David Hallengärd

Since Specialization
Citations

This map shows the geographic impact of David Hallengärd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hallengärd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hallengärd more than expected).

Fields of papers citing papers by David Hallengärd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hallengärd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hallengärd. The network helps show where David Hallengärd may publish in the future.

Co-authorship network of co-authors of David Hallengärd

This figure shows the co-authorship network connecting the top 25 collaborators of David Hallengärd. A scholar is included among the top collaborators of David Hallengärd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hallengärd. David Hallengärd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roques, Pierre, Karl Ljungberg, Beate M. Kümmerer, et al.. (2017). Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus. JCI Insight. 2(6). e83527–e83527. 70 indexed citations
2.
Hinkula, Jorma, Stefan Petkov, Karl Ljungberg, et al.. (2017). HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV. Heliyon. 3(6). e00339–e00339. 10 indexed citations
3.
Couderc, Thérèse, Lisa F. P. Ng, David Hallengärd, et al.. (2015). Therapeutics and Vaccines Against Chikungunya Virus. Vector-Borne and Zoonotic Diseases. 15(4). 250–257. 53 indexed citations
4.
Ljungberg, Karl, Maria Kakoulidou, David Hallengärd, et al.. (2014). Kinetic and Phenotypic Analysis of CD8 + T Cell Responses after Priming with Alphavirus Replicons and Homologous or Heterologous Booster Immunizations. Journal of Virology. 88(21). 12438–12451. 29 indexed citations
5.
Bråve, Andreas, David Hallengärd, Ronza Hadad, et al.. (2014). Oral delivery of plant-derived HIV-1 p24 antigen in low doses shows a superior priming effect in mice compared to high doses. Vaccine. 32(20). 2288–2293. 29 indexed citations
6.
Wiklander, Oscar P. B., Janne J. Turunen, Joel Z. Nordin, et al.. (2014). Micro-minicircle Gene Therapy: Implications of Size on Fermentation, Complexation, Shearing Resistance, and Expression. Molecular Therapy — Nucleic Acids. 3. e140–e140. 28 indexed citations
7.
Hallengärd, David, Britta Wahrén, & Andreas Bråve. (2013). A Truncated Plasmid-Encoded HIV-1 Reverse Transcriptase Displays Strong Immunogenicity. Viral Immunology. 26(2). 163–166. 4 indexed citations
8.
Nilsson, Charlotta, Karina Godoy‐Ramirez, Bo Hejdeman, et al.. (2013). Broad and Potent Cellular and Humoral Immune Responses After a Second Late HIV-Modified Vaccinia Virus Ankara Vaccination in HIV-DNA-Primed and HIV-Modified Vaccinia Virus Ankara-Boosted Swedish Vaccinees. AIDS Research and Human Retroviruses. 30(3). 299–311. 23 indexed citations
9.
Starodubova, Elizaveta, Stefan Petkov, David Hallengärd, et al.. (2013). Consensus HIV-1 FSU-A Integrase Gene Variants Electroporated into Mice Induce Polyfunctional Antigen-Specific CD4+ and CD8+ T Cells. PLoS ONE. 8(5). e62720–e62720. 10 indexed citations
10.
Hallengärd, David, Steven E. Applequist, Sanna Nyström, et al.. (2012). Immunization with Multiple Vaccine Modalities Induce Strong HIV-Specific Cellular and Humoral Immune Responses. Viral Immunology. 25(5). 423–432. 8 indexed citations
11.
Hallengärd, David, Andreas Bråve, Maria Isaguliants, et al.. (2012). A combination of intradermal jet-injection and electroporation overcomes in vivodose restriction of DNA vaccines. PubMed. 10(1). 5–5. 22 indexed citations
12.
Ruffin, Nicolas, Zelda Euler, Fabio Fiorino, et al.. (2012). Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011. Journal of Translational Medicine. 10(1). 5 indexed citations
13.
14.
Katinger, Dietmar, S. A. Jeffs, Friedrich Altmann, et al.. (2012). CN54gp140: product characteristics, peclinical and clinical use - recombinant glycoprotein for HIV immunization. Retrovirology. 9(S2). 3 indexed citations
15.
Hallengärd, David, et al.. (2011). Comparison of Plasmid Vaccine Immunization Schedules Using IntradermalIn VivoElectroporation. Clinical and Vaccine Immunology. 18(9). 1577–1581. 26 indexed citations
16.
Bråve, Andreas, Lindvi Gudmundsdotter, Eric Sandström, et al.. (2010). Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation. Vaccine. 28(51). 8203–8209. 38 indexed citations
17.
Bråve, Andreas, Ulrika Johansson, David Hallengärd, et al.. (2009). Induction of HIV-1-specific cellular and humoral immune responses following immunization with HIV-DNA adjuvanted with activated apoptotic lymphocytes. Vaccine. 28(9). 2080–2087. 13 indexed citations
18.
Bråve, Andreas, David Hallengärd, Lindvi Gudmundsdotter, et al.. (2009). Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen. Vaccine. 27(28). 3692–3696. 19 indexed citations
19.
Bråve, Andreas, David Hallengärd, Maria Malm, et al.. (2008). Combining DNA technologies and different modes of immunization for induction of humoral and cellular anti-HIV-1 immune responses. Vaccine. 27(2). 184–186. 5 indexed citations
20.
Bråve, Andreas, David Hallengärd, Ulf Schröder, et al.. (2008). Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses. Vaccine. 26(40). 5075–5078. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan King Breakdown of academic impact, for papers by Jorge Reyes‐del Valle Breakdown of academic impact, for papers by Wataru Akahata Breakdown of academic impact, for papers by Jérôme Salmon Breakdown of academic impact, for papers by Michael G. Raum Breakdown of academic impact, for papers by Lesley C. Dupuy Breakdown of academic impact, for papers by Jayati Mullick Breakdown of academic impact, for papers by Itaru Anraku Breakdown of academic impact, for papers by S. Kyle Austin Breakdown of academic impact, for papers by Samantha Brandler
Rankless by CCL
2026